Emmanuel Gyan
Université de Tours(FR)Inserm(FR)Inserm(FR)Centre Hospitalier Universitaire de Tours(FR)Bretonneau Hospital(FR)Hôpital Bretonneau(FR)Clinical Investigation Center Plurithematic Tours(FR)Thion Medical (France)(FR)Centre Val de Loire(FR)Laboratoire d'Informatique Fondamentale et Appliquée de Tours(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, CAR-T cell therapy research
Most-Cited Works
- → Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial(2018)593 cited
- → Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease(2007)444 cited
- → High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial(2014)322 cited
- → Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia(2020)312 cited
- → Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study(2019)268 cited
- → Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas